A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)

Recruiting

Phase 1

TSR-022A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)

Sponsor:

Tesaro, Inc.

Code:

NCT02817633

Conditions

Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TSR-022

Nivolumab

TSR-042

TSR-033

Docetaxel

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-15. This information was provided to ClinicalTrials.gov by Tesaro, Inc. on 2024-06-20.